Terms: = Thyroid cancer AND NAB2, MADER, 4665, ENSG00000166886, Q15742, MGC75085 AND Clinical Outcome
1 results:
1. Comparison of thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone administration for adjuvant therapy in patients with intermediate- to high-risk differentiated thyroid cancer.
Iizuka Y; Katagiri T; Ogura K; Inoue M; Nakamura K; Mizowaki T
Ann Nucl Med; 2020 Oct; 34(10):736-741. PubMed ID: 32643022
[TBL] [Abstract] [Full Text] [Related]
